“In a retrospective study conducted using PAC+, almost half the number of patients could be safely down-triaged from higher (P1-P2) to lower priority levels (P3-P4). This could help to ease the emergency department’s caseload, allowing more resources to be diverted to looking after critically ill patients,” explained Wong.
The PAC+ team hopes that their model can help identify patients who may be suitable for discharge, referred to primary care, or admitted under Mobile Inpatient Care @ Home (MIC@Home), a programme that provides hospital-level care to patients in their homes.
Associate Professor Christopher Laing, Vice-Dean, Office of Innovation & Entrepreneurship at Duke-NUS, said: “Artificial intelligence is the future of medicine, with immense potential to solve complex clinical problems. Our scientists and students are working with industry partners and entrepreneurs to bring new AI technologies to medical practice, where they can make a meaningful impact to patients.”
Duke-NUS commercialisation impact has included therapeutics, vaccines, diagnostics, medical devices, and digital health technologies, developed to combat our society’s greatest emerging health challenges.